Factors independently associated with odds of fractures Adjusted odds ratio (95% CI) No warfarin Reference group <1-y warfarin therapy 1.03 (0.82-1.29) >1-y warfarin therapy 1.25 (1.06-1.48) Men (>1-y warfarin therapy) 1.63 (1.26-2.10) Women (>1-y warfarin therapy) 1.05 (0.88-1.26) Warfarin use on discharge* 0.95 (0.81-1.11) Age (10-year increase) 1.63 (1.47-1.80) African American race 0.30 (0.18-0.51) *Forced into model to prevent confounding Gage BF et al. Arch Intern Med 2006; 166:241-246. Long-term use of warfarin increases risk of fracture in men [Rheumawire > News; Jan 27, 2006
Factors independently associated with odds of fractures Adjusted odds ratio (95% CI) No warfarin Reference group Male sex 0.54 (0.46-0.62) Beta-blocker use 0.84 (0.70-1.00) Heart failure 0.86 (0.75-0.98) High fall risk 1.78 (1.42-2.21) Hyperthyroidism 1.77 (1.16-2.70) Neuropsychiatric impairment 1.51 (1.28-1.78) Alcoholism 1.50 (1.01-2.24) Corticosteroid use* 1.24 (0.97-1.58) *Forced into model to prevent confounding Gage BF et al. Arch Intern Med 2006; 166:241-246. Long-term use of warfarin increases risk of fracture in men [Rheumawire > News; Jan 27, 2006